S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 CymaBay TherapeuticsNeptune Wellness SolutionsProvention BioBioDelivery Sciences InternationalCollegium Pharmaceutical
SymbolNASDAQ:CBAYNASDAQ:NEPTNASDAQ:PRVBNASDAQ:BDSINASDAQ:COLL
Price Information
Current Price$4.93$3.43$6.07$5.27$11.86
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$14.00N/A$20.25$6.50$26.20
% Upside from Price Target183.98% upsideN/A233.61% upside23.34% upside121.00% upside
Trade Information
Market Cap$326.33 million$317.10 million$236.91 million$461.04 million$404.32 million
Beta1.321.845.790.330.52
Average Volume879,057904,068428,987876,424355,654
Sales & Book Value
Annual Revenue$10 million$18.39 millionN/A$55.64 million$280.41 million
Price / Sales33.8717.24N/A8.481.42
CashflowN/AN/AN/AN/A$2.12 per share
Price / CashN/AN/AN/AN/A5.60
Book Value$2.87 per share$0.66 per share$1.76 per share$0.42 per share$2.75 per share
Price / Book1.725.20N/A12.554.31
Profitability
Net Income$-72,550,000.00$-17,670,000.00$-26,480,000.00$-33,870,000.00$-39,130,000.00
EPS($1.26)($0.14)($1.19)($0.73)($1.19)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/A11.06N/A19.5279.03
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-107.62%N/A-34.73%-7.45%
Return on Equity (ROE)-39.95%-23.18%-64.53%-0.85%-26.10%
Return on Assets (ROA)-37.09%-19.01%-61.30%-0.27%-5.69%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.01%N/AN/A0.88%0.23%
Current Ratio16.20%1.21%8.43%2.34%1.25%
Quick Ratio16.20%0.82%8.43%2.09%1.20%
Ownership Information
Institutional Ownership Percentage98.60%11.84%5.62%68.51%92.07%
Insider Ownership Percentage4.20%N/A19.60%8.94%8.08%
Miscellaneous
Employees435813164266
Shares Outstanding68.70 million92.45 million39.35 million89.52 million33.47 million
Next Earnings Date11/5/2019 (Estimated)11/12/2019 (Estimated)11/14/2019 (Estimated)11/14/2019 (Estimated)11/14/2019 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable
 CymaBay TherapeuticsNeptune Wellness SolutionsProvention BioBioDelivery Sciences InternationalCollegium Pharmaceutical

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel